Erin Graves | executive |
Mark Goldsmith | executive |
Jack Anders | executive |
Marc Frahm | analyst |
Michael Schmidt | analyst |
Stephen Kelsey | executive |
Eric Joseph | analyst |
Jonathan Chang | analyst |
Eliana Merle | analyst |
Poorna Kannan | analyst |
Wei Lin | executive |
Alec Stranahan | analyst |
Laura Prendergast | analyst |
Benjamin Burnett | analyst |
Good day, and thank you for standing by. Welcome to the Revolution Medicines First Quarter 2024 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your first speaker today, Erin Graves, Senior Director of Corporate Communications and Investor Relations. Please go ahead.